| Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges K Sivaraman Siveen, K Prabhu, R Krishnankutty, S Kuttikrishnan, ... Current vascular pharmacology 15 (4), 339-351, 2017 | 234 | 2017 |
| RAS-mediated oncogenic signaling pathways in human malignancies AQ Khan, S Kuttikrishnan, KS Siveen, KS Prabhu, M Shanmugakonar, ... Seminars in cancer biology 54, 1-13, 2019 | 185 | 2019 |
| Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products KS Siveen, KS Prabhu, IW Achkar, S Kuttikrishnan, S Shyam, AQ Khan, ... Molecular cancer 17, 1-21, 2018 | 150 | 2018 |
| Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance AA Bhat, SN Younes, SS Raza, L Zarif, S Nisar, I Ahmed, R Mir, S Kumar, ... Molecular cancer 19, 1-21, 2020 | 123 | 2020 |
| Curcumin induces apoptotic cell death via inhibition of PI3-kinase/AKT pathway in B-precursor acute lymphoblastic leukemia S Kuttikrishnan, KS Siveen, KS Prabhu, AQ Khan, EI Ahmed, S Akhtar, ... Frontiers in oncology 9, 484, 2019 | 82 | 2019 |
| Dysregulated FOXM1 signaling in the regulation of cancer stem cells G Sher, T Masoodi, K Patil, S Akhtar, S Kuttikrishnan, A Ahmad, S Uddin Seminars in cancer biology 86, 107-121, 2022 | 71 | 2022 |
| The role of extracellular vesicles as modulators of the tumor microenvironment, metastasis and drug resistance in colorectal cancer KS Siveen, A Raza, EI Ahmed, AQ Khan, KS Prabhu, S Kuttikrishnan, ... Cancers 11 (6), 746, 2019 | 51 | 2019 |
| Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway KS Prabhu, AA Bhat, KS Siveen, S Kuttikrishnan, SS Raza, T Raheed, ... Biomedicine & Pharmacotherapy 144, 112358, 2021 | 49 | 2021 |
| Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways K Patil, S Kuttikrishnan, AQ Khan, F Ahmad, M Alam, J Buddenkotte, ... Seminars in Cancer Biology 86, 382-399, 2022 | 48 | 2022 |
| Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells KS Prabhu, KS Siveen, S Kuttikrishnan, A Iskandarani, M Tsakou, ... PLoS One 12 (7), e0180895, 2017 | 48 | 2017 |
| Natural products as chemo-radiation therapy sensitizers in cancers S Nisar, T Masoodi, KS Prabhu, S Kuttikrishnan, L Zarif, S Khatoon, S Ali, ... Biomedicine & Pharmacotherapy 154, 113610, 2022 | 46 | 2022 |
| Non-coding RNAs as regulators and markers for targeting of breast cancer and cancer stem cells KS Prabhu, A Raza, T Karedath, SS Raza, H Fathima, EI Ahmed, ... Cancers 12 (2), 351, 2020 | 46 | 2020 |
| Sanguinarine induces apoptosis pathway in multiple myeloma cell lines via inhibition of the JaK2/STAT3 signaling S Akhtar, IW Achkar, KS Siveen, S Kuttikrishnan, KS Prabhu, AQ Khan, ... Frontiers in Oncology 9, 285, 2019 | 43 | 2019 |
| Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia S Kuttikrishnan, KS Siveen, KS Prabhu, AQ Khan, S Akhtar, JM Mateo, ... Leukemia & Lymphoma 60 (3), 782-794, 2019 | 40 | 2019 |
| Potential therapeutic targets of Guggulsterone in cancer AA Bhat, KS Prabhu, S Kuttikrishnan, R Krishnankutty, J Babu, ... Nutrition & metabolism 14, 1-11, 2017 | 39 | 2017 |
| Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells A Iskandarani, AA Bhat, KS Siveen, KS Prabhu, S Kuttikrishnan, MA Khan, ... Journal of Translational Medicine 14, 1-12, 2016 | 36 | 2016 |
| Sanguinarine induces apoptosis in papillary thyroid cancer cells via generation of reactive oxygen species AQ Khan, EAN Mohamed, I Hakeem, A Nazeer, S Kuttikrishnan, ... Molecules 25 (5), 1229, 2020 | 34 | 2020 |
| Seminars in cancer biology AQ Khan, S Kuttikrishnan, KS Siveen, KS Prabhu, M Shanmugakonar, ... Flavonoids nanoparticles in cancer: Treatment, prevention and clinical …, 2021 | 32 | 2021 |
| Embelin: A benzoquinone possesses therapeutic potential for the treatment of human cancer KS Prabhu, IW Achkar, S Kuttikrishnan, S Akhtar, AQ Khan, KS Siveen, ... Future medicinal chemistry 10 (8), 961-976, 2018 | 31 | 2018 |
| H2AX: A key player in DNA damage response and a promising target for cancer therapy KS Prabhu, S Kuttikrishnan, N Ahmad, U Habeeba, Z Mariyam, ... Biomedicine & Pharmacotherapy 175, 116663, 2024 | 29 | 2024 |
Shahab Uddin, PhDSenior Scientist Hamad Medical CorporationVahvistettu sähköpostiosoite verkkotunnuksessa hamad.qa
